Release date- 20102016 - F. Hoffmann-La Roche Ltd. (hereafter 'Roche') [Head Office: Basel, Switzerland. CEO: Severin Schwan] announced today its third quarter sales 2016 (January 1 - September 30, 2016). Roche owns 59.89% of Chugai's outstanding ... 4 Traders, 5 days ago
Researchers from F. Hoffmann-La Roche Report New Studies and Findings in the Area of Immunoglobulins (Introduction to the application of QbD... - 4 Traders, 6 days ago
Retinopathy of Prematurity Pipeline Review 2016 Featuring Biomar Microbial Technologies & F. Hoffmann-La Roche Ltd. - Research and Markets - TMC Net, 5 days ago
Influenza Market 2015-2020: Global Industry Perspective, Comprehensive Analysis and Forecasts Featuring AstraZeneca, F. Hoffmann-La Roche,...
Influenza Market 2015-2020: Global Industry Perspective, Comprehensive Analysis and Forecasts Featuring AstraZeneca, F. Hoffmann-La Roche, GlaxoSmithKline, Novartis, Sanofi-Pasteur - Research and Markets By a News Reporter-Staff News Editor at ...Pharmacy Choice, 1 month ago Lung Cancer Therapeutics Market - Latest Trends & Insights 2023 MyNewsDesk, 1 day ago Transitional Cell Cancer (Urothelial Cell Cancer) Therapeutics Global Clinical Trials Industry Review, H2, 2016 Before It's News, 2 days ago Artificial Lungs Industry - Manufacturing Process, Cost Research, Projections 2016-2021 Digital Journal, 5 days ago
Roche has secured approval from the US Food and Drug Administration (FDA) for its fully automated blood screening assay for use on the cobas 6800 and 8800 systems. The donor screening laboratories can use the cobas MPX test to apply an advanced ...Medical Devices Business Review, 2 days ago FDA approves Genentech's Tecentriq for metastatic non-small cell lung cancer Pharmaceutical Business Review, 1 week ago Roche's Actemra/RoActemra gets FDA breakthrough therapy status for giant cell arteritis Pharmaceutical Business Review, 3 weeks ago A Pipeline Preview of 2016 FDA Approvals in Hematology/Oncology Oncology Pharmacist.com, 1 week ago
TechNavio - Infiniti Research Ltd. Global Cystic Fibrosis Therapeutics Market 2016-2020 About Cystic Fibrosis Cystic fibrosis, also known as mucoviscidosis, is a genetically inherited, chronic disease and is progressive in nature. The onset ...MarketResearch.com, 6 days ago Global Metabolic Disorders Therapeutics Market 2016-2020 MarketResearch.com, 1 week ago Global Gastrointestinal Therapeutics Market 2016-2020 MarketResearch.com, 1 week ago Global Central Nervous System Disorders Therapeutics Market 2016-2020 MarketResearch.com, 2 weeks ago
Release date- 17102016 - Saint-Prex, Switzerland - Ferring Pharmaceuticals announced today that the Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for REKOVELLE (follitropin delta), recommending that the ...4 Traders, 1 week ago EMA committee recommends marketing approval for Ferring's Rekovell for use in controlled ovarian stimulation PharmaBiz, 1 week ago Ferring receives positive CHMP opinion for REKOVELLE® (follitropin delta) 4 Traders, 1 week ago Ferring Pharma Receives Positive CHMP Opinion For REKOVELLE (Follitropin Delta) BioSpace, 1 week ago
TechNavio - Infiniti Research Ltd. Global Age-related Macular Degeneration Market 2016-2020 About AMD AMD is the degeneration or disintegration of the eye's macula. The macula is a small area of the retina that is responsible for the central ...MarketResearch.com, 1 week ago
(Before It's News) Global Smart Wearable Fitness Devices Sensors Market 2016 WiseGuyReports.Com Publish a New Market Research Report On Global Smart Wearable Fitness Devices Sensors Market 2016 Share,Trend,Segmentation and Forecast to 2021. ...Before It's News, 7 hours ago
Global Chemotherapy Market Research Report 2016 Order This Report by calling BigMarketResearch.com at +1-971-202-1575 Notes: Production, means the output of Chemotherapy Revenue, means the sales value of Chemotherapy This report ...Before It's News, 8 hours ago CNS Therapeutics 2016 Sales and Forecast to 2021 Market Research Report Before It's News, 2 weeks ago Global CNS Therapeutics Industry: Market Research to 2020 Before It's News, 2 weeks ago CNS Therapeutics Global Market Research Report 2016 PharmiWeb, 3 weeks ago
According to Publisher, the Global Telemedicine market is accounted for $19.3 billion in 2015 and is expected to reach $52.3 billion by 2022 growing at a CAGR of 15.3% from 2015 to 2022. Factors such as technological innovation, increasing remote ...Before It's News, 11 hours ago Global Immunotherapy Drugs to grow at a CAGR of 11.52% during 2016-2020 MyNewsDesk, 2 days ago Melanoma Therapeutics Market to Record an Impressive Growth Rate During the Forecast 2015 to 2021 MyNewsDesk, 6 days ago Cardiovascular Drugs Market Would Register a Healthy Growth Rate During the Forecast 2015 to 2021 MyNewsDesk, 1 week ago
More from: , Pharmacy Choice...and 3 other sources
The global market for Kaposi sarcoma is projected to expand at a modest 2.2% CAGR from 2016 to 2024, with the opportunity in the market rising from US$118.5 mn in 2015 to be worth US$143.2 mn by the end of the forecast period. Hospitals formed the ...MyNewsDesk, 1 day ago Kaposi Sarcoma Market: Patent Expiry of Blockbuster Drugs for Treatment of Kaposi Sarcoma to Present Lucrative Opportunities Digital Journal, 2 weeks ago Global Kaposi Sarcoma Market is Expected to Reach US$143.2 mn by 2024 MyNewsDesk, 2 weeks ago
on your WebpageAdd Widget >Get your members hooked!